<DOC>
	<DOC>NCT01029535</DOC>
	<brief_summary>This is a prospective, open-label experience study to be conducted at 6 clinical sites in Australia, with the objective to collect efficacy and safety information for Juvederm® VOLUMA™ when used for volumising the mid-face and cheek area.</brief_summary>
	<brief_title>Safety and Efficacy of Juvederm® VOLUMA™ for Correction of Mid-face Volume Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>Subjects with mild to severe midface and cheek volume deficit due to agerelated changes, who are likely to improve by at least 2 grades following treatment with the study compound, based on a studyspecific scale, as assessed by the study physician Subjects who have a preexisting medical condition or who have received any treatments or procedures which may impact on the assessment of the effects of the study compound. Subjects with a history of allergies or other side effects to dermal fillers, lidocaine, hyaluronic acid or other component of the study compound. Subjects were are pregnant or breastfeeding or who are of childbearing potential and who are not prepared to practice an adequate form of contraception during the course of the study Subjects with a history of alcoholism or drug abuse or dependence</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>